Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2013; 19(48): 9366-9376
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9366
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9366
Table 1 Gene specific primers for polymerase chain reaction amplification and dissociation analysis
Gene | Forward primer | Reverse primer |
MCP1-2518 | TTTCTTGACAGAGCAGAAGTGGGAG | TTGCTGGCTGAGTGTTCACATAGG |
CCR2 190 | ATACCAACGAGAGCGGTGAAGAAG | AAAGCAGATCAGAGATGGCCAGG |
IL10-592 | AAAGGAGCCTGGAACACATCCTGT | AAAGTTCCCAAGCAGCCCTTCCAT |
IL10-1082 | TCCAAGACAACACTACTAAGGCTTC | GCTGGATAGGAGGTCCCTTACTTT |
TGF-β | CTACCGCTGCTGTGGCTACTGGT | TCACCAGCTCCATGTCGATAGTCT |
TLR4-299 | CCGATTAGCATACTTAGACTACTACCTC | CCTTTCAATAGTCACACTCACCAGG |
TLR4-399 | GCTTGAGTTTCAAAGGTTGCTGTTCTC | GCCCAAGAAGTTTGAACTCATGGTAA |
hOGG1 | ACCCTCCTACAGGTGCTGTTCAGT | CCTTTGGAACCCTTTCTGCGCTTT |
Table 2 Polymerase chain reaction profiles for candidate gene high resolution melt analysis
Gene | Annealing temperature | Extension temperature | Melt analysis range |
MCP-1 | 58 °C | 72 °C | 74 to 84 °C |
CCR-2 | 58 °C | 72 °C | 74 to 84 °C |
IL10-592 | 57 °C | 72 °C | 75 to 85 °C |
IL10-1082 | 59 °C | 72 °C | 70 to 81 °C |
TGF-β | 65 °C (20 s) | 72 °C (20 s) | 79 to 89 °C |
TLR4 299 | 57 °C | 68 °C | 66 to 78 °C |
TLR4 399 | 58 °C | 70 °C | 69 to 81 °C |
hOGG1 | 57 °C | 68 °C | 78 to 88 °C |
Table 3 Patient characteristics grouped according to the presence or absence of hepatic fibrosis (univariate analysis) n (%)
Parameter | No fibrosis (n = 136) | Fibrosis present (n = 109) | P value |
Male gender | 72 (53) | 89 (82) | 0.0001 |
Age at biopsy (yr) (mean ± SD) | 39.7 (14.9) | 44.3 (12.4) | 0.006 |
Alcohol (g/d) (median: range) | 5 (0-120) | 20 (0-200) | 0.0001 |
Steatosis present1 | 36 (37) | 42 (53) | 0.03 |
Serum ferritin (μg/L) (median: range) | 531 (33-3000) | 2134 (155-6000) | 0.0001 |
HIC (μmol/g dw) (median: range) | 124 (20-537) | 218 (43-847) | < 0.0001 |
Iron grade | |||
0 | 1 (1) | 0 | |
1 | 5 (4) | 0 | |
2 | 27 (20) | 7 (6) | |
3 | 63 (46) | 25 (23) | |
4 | 40 (29) | 77 (71) | < 0.0001 |
Table 4 Allele frequency in candidate genes assessed in patient and control groups by high resolution melt analysis: Compared to published data for Caucasian ethnicity populations
Gene | Patient group | Control group | Published results1 |
MCP1 | A 0.729 | A 0.736 | A 0.695 |
G 0.271 | G 0.264 | G0.305 | |
CCR2 | G 0.892 | G 0.976 | G 0.892 |
A 0.108 | A 0.024 | A 0.108 | |
TGFβ | G 0.918 | G 0.892 | G 0.887 |
C 0.082 | C 0.108 | C 0.113 | |
hOGG1 | C 0.695 | C 0.694 | C 0.776 |
G 0.305 | G 0.306 | G 0.224 | |
IL10-1082 | G 0.539 | G 0.500 | G0.531 |
A 0.461 | A 0.500 | A 0.469 | |
IL10-592 | C 0.794 | C 0.794 | C 0.792 |
A 0.206 | A 0.206 | A 0.208 | |
TLR4 299 | A 0.934 | A 0.930 | A 0.967 |
G 0.066 | G 0.070 | G 0.033 | |
TLR4 399 | C 0.934 | C 0.931 | C 0.955 |
T 0.066 | T 0.069 | T 0.045 |
Table 5 Genetic polymorphisms in Hereditary Haemochromatosis patients grouped according the presence or absence of advanced fibrosis and subjected to univariate analysis n (%)
Gene | No/minimal fibrosis (F0-2) | Advanced fibrosis (F3-4) | P value |
MCP1 | |||
AA | 99 (53.5) | 28 (46.7) | |
AG | 76 (41.1) | 27 (45.0) | |
GG | 10 (5.4) | 5 (8.3) | 0.546 |
CCR2 | |||
GG | 142 (78.0) | 50 (84.8) | |
AG | 37 (20.3) | 9 (15.3) | |
AA | 3 (1.7) | 0 (0) | 0.401 |
TGFβ | |||
GG | 154 (83.2) | 51 (85) | |
GC | 31 (16.8) | 9 (15) | 0.749 |
hOGG1 | |||
CC | 99 (53.8) | 26 (43.3) | |
CG | 64 (34.8) | 25 (41.7) | |
GG | 21 (11.4) | 9 (15) | 0.352 |
IL10-1082 | |||
GG | 50 (27.1) | 17 (28.3) | |
GA | 97 (52.4) | 33 (55.0) | |
AA | 38 (20.5) | 10 (16.7) | 0.806 |
IL10-592 | |||
CC | 120 (64.9) | 37 (61.7) | |
AC | 58 (31.3) | 17 (28.3) | |
AA | 7 (3.8) | 6 (10.0) | 0.173 |
TLR4 299 | |||
AA | 159 (86.4) | 54 (91.5) | |
AG | 24 (13.0) | 4 (6.8) | |
GG | 1 (0.6) | 1 (1.7) | 0.305 |
TLR4 399 | |||
CC | 161 (87.0) | 53 (89.8) | |
CT | 23 (12.4) | 5 (8.5) | |
TT | 1 (0.5) | 1 (1.7) | 0.502 |
Table 6 Multivariate ordered logistic regression analysis determining role of genetic polymorphisms in increasing hepatic fibrosis stage
Gene | OR | 95%CI | P value | Adjusted P value1 |
MCP1 | 1.11 | 0.69-1.80 | 0.660 | 0.681 |
CCR2 | 0.71 | 0.36-1.32 | 0.284 | 0.432 |
TGFβ | 1.03 | 0.54-1.95 | 0.936 | 0.740 |
hOGG1 | 0.94 | 0.44-1.98 | 0.864 | 0.588 |
IL10-1082 | 1.10 | 0.65-1.88 | 0.720 | 0.897 |
IL10-592 | 0.82 | 0.50-1.35 | 0.441 | 0.639 |
TLR4 299 | 0.73 | 0.35-1.53 | 0.403 | 0.745 |
TLR4 399 | 0.87 | 0.42-1.81 | 0.706 | 0.990 |
Table 7 Genetic polymorphism frequencies in patients with heavy iron loading (Grade 3 and 4) grouped according to no fibrosis (F0) vs advanced fibrosis (F3/F4)
Gene | No fibrosis (F0) (n = 103) | Advanced fibrosis (F3/4) (n = 60) | P value | Adjusted P value1 | ||
MCP1 | AA 53/103 | AG/GG | AA 28/60 | AG/GG 32/60 | 0.555 | 0.433 |
51.50% | 50/103 48.5% | 46.70% | 53.3% | |||
CCR2 | GG 81/100 | AG/AA | GG 50/59 | AG/AA 9/59 | 0.549 | 0.277 |
81% | 19/100 19% | 84.70% | 15.3% | |||
TGF β | GG 86/103 | CG/CC 17/103 | GG 51/60 | CG/CC 9/60 | 0.800 | 0.968 |
83.50% | 16.5% | 85% | 15% | |||
hOGG1 | CC 54/102 | CG/GG 48/102 | CC 26/60 | CG/GG 34/60 | 0.238 | 0.790 |
52.90% | 47.1% | 43.30% | 56.7% | |||
IL10-1082 | AA/AG 75/103 | GG 28/103 | AA/AG 43/60 | GG 17/60 | 0.874 | 0.998 |
72.8% | 27.20% | 71.80% | 28.30% | |||
IL10-592 | AA/AC 34/103 | CC 66/103 | AA/AC 23/60 | CC 37/60 | 0.492 | 0.659 |
33.0% | 67.0% | 38.3% | 61.7% | |||
TLR4 299 | AA 87/102 | AG/GG 15/102 | AA 54/59 | AG/GG 5/59 | 0.248 | 0.848 |
85.3% | 14.7% | 91.5% | 8.5% | |||
TLR4 399 | CC 89/103 | CT/TT 14/103 | CC 53/59 | CT/TT 6/59 | 0.524 | 0.985 |
86.4% | 13.6% | 89.8% | 10.2% |
Table 8 Logistic regression analysis performed in subjects with HIC > 236 μmol/g dw and comparing outcome of F0 vs F3/4 (univariate analysis) (n = 47)
Factor | OR | 95%CI | P value |
Age | 1.07 | 1.00-1.15 | 0.034 |
Alcohol | 1.03 | 1.01-1.05 | 0.011 |
Female gender | 0.27 | 0.05-1.55 | 0.140 |
MCP1 | 1.20 | 0.37-3.87 | 0.76 |
CCR2 | 0.74 | 0.13-4.12 | 0.73 |
TGFβ | 0.58 | 0.09-3.52 | 0.553 |
hOGG1 | 1.50 | 0.47-4.77 | 0.492 |
IL10-1082 | 1.89 | 0.48-7.44 | 0.363 |
IL10-592 | 0.98 | 0.30-3.21 | 0.980 |
TLR4 299 | 1.17 | 0.77-7.79 | 0.868 |
TLR4 399 | 1.24 | 0.19-8.19 | 0.824 |
- Citation: Wood MJ, Powell LW, Dixon JL, Subramaniam VN, Ramm GA. Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis. World J Gastroenterol 2013; 19(48): 9366-9376
- URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9366.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i48.9366